drugset / Trial / NCT06804980

DESIFOR-EXPAND (MHIF)

NCT06804980

Phase 4 Recruiting 100 enrolled Minneapolis Heart Institute Foundation
RandomizedSingle-groupTriple-blindTreatment

Summary

The DESIFOR pilot study was conducted to determine the feasibility of utilizing an n-of-1 trial to facilitate tolerance of unblinded rosuvastatin in patients with prior statin intolerance

Timeline

Start
2025-02-01
Primary completion
2026-12-31
Completion
2026-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosuvastatin Small molecule

Indications